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Summary The effect of LiCI on melanoma cell growth and differentiationl was studied in mouse and human
melanoma cell lines. LiCI markedly inhibited B16 and HT-144 melanoma cell growth in iitro. Clonogenicity
in soft agar of the melanoma cells was also markedly inhibited by LiCl. Pretreatmelnt of B16 mouse
melanoma cells with LiCl delayed the appearance of melanoma tumours in syngeneic mice. Growth inhibition
of cells was accompanied by morphological and biochemical alterations. LiCl induced cell enlargement and
formation of dendrite-like structures. The activity of NADPH cytochrome c reductase, an enzymatic marker
of endoplasmic reticulum was significantly (2-3 fold) increased. Addition of myo-inositol to cell cultures
partially reversed the anti-proliferative and morphological effects of LiCl on melanoma cells. This finding may
suggest that the anti-proliferative effect of LiCl is related to its effect on phosphatidylinositol metabolism.
,\4onovalent cations play a role in regulation of cell growth
and differentiation. Lithium has been shown to stimulate
growth of several normal and cancer cells. 3T3 mouse
1ibroblasts, mammary epithelial cells and mammary tumour
cells were stimulated to proliferate by lithium chloride
(LiCI) (Ptashne et al., 1980; Hori & Oka, 1979; Rybak &
Stockdale, 1981). This agent also potentiated the mitogenic
response of B and T cells (Hart 1981, 1982; Bray et al.,
'981).
LiCl was found to modulate haematopoiesis by influencing
pluripotential and committed stem cell proliferation and
differentiation toward granulocytes (Gallicchio & Chen,
1981; Morley & Galbraith, 1978; Levitt & Quesenberg,
1980). Axolotl-embryo's ectodermal cells were induced to
differentiate into mesenchyme, nerve cells and melanophores
by LiCl (Lovtrop & Perris, 1983). LiCI has also been shown
to potentiate the anti-melanoma effect of bleomycin in mice
bearing melanoma tumours (Ballin et al., 1983).
The biochemical basis of lithium's actions on cell growth
and differentiation is unknown. However, in different tissues
lithium has been shown to affect cyclic nucleotide levels
(Dovsa & Mecher, 1970; Wang et al., 1974) glucose
metabolism (Nordenberg et al., 1982; Dempsey et al., 1976)
and phosphatidylinositol metabolism (Allison & Stewart,
1971; Allison et al., 1976; Berridge & Irvine, 1984).
In the present study the direct effect of LiCl on melanoma
cell growth and differentiation is evaluated. We demonstrate
that LiCI inhibits melanoma cell growth and clonogenicity
and delays the appearance of tumours in syngeneic mice.
The anti-proliferative effects of LiCl are accompanied by
morphological and biochemical phenotypic alterations.
Addition of myo-inositol to cell cultures partially reverses
the effects of LiCl on melanoma cells. This finding may
suggest that the anti-proliferative effect on LiCl is related to
its effect on phosphatidylinositol metabolism.
Materials and methods
Celts, nmedia and reagents
A melanotic clone of mouse B16 melanoma FIO, kindly
donated by Dr Abraham Raz, the Weizmann Institute, was
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used in most experiments. In selected experiments a human
amelanotic melanoma cell line HT-144 from the American
Type Culture Collection, Maryland was used. The cells were
cultured in RPMI 1640, supplemented with 10% foetal calf
serum and antibiotics, at 37'C in a humidified atmosphere of
5% CO2 and 95% air. B16 FIO cells were passaged three
times weekly and HT-144 cells 1-2 times weekly. Media and
supplements were obtained from Biol. Industries, Israel and
lithium chloride from BDH chemicals, Ltd., Poole, UK.
Cell growitth e:xperinments
In most cases 105 cells were plated in 1.5ml culture medium,
in 3.5cm culture dishes. When cells were cultured for more
than 3 days, 3 x 104 cells were plated in 10ml culture
medium in 8.5cm culture dishes. This was done to avoid cell
crowding. Two to four hours later, after most cells were
attached to the bottom of the petri dish, LiCI or myo-
inositol were added as indicated in legend to Figure 1 and
Table IV. The cultures were refed every 48 h with growth
medium supplemented with LiCl. Cell growth was
determined by counting the cell number after 1, 2 and 4 days
in culture. The human line had a relatively lower
proliferation rate, and therefore the effect of LiCI on cell
number was determined after 3 to 5 days of treatment. The
cells were detached with EDTA (1 mM) and counted in a
Coulter counter. Viability of the cells was assessed by the
trypan blue dye exclusion test.
Clonogenic assay
The effect of LiCI, in the presence and absence of myo-
inositol, on the clonogenic potential of F-10 melanoma stem
cells was investigated by modification (Eliason et al., 1984)
of the soft agar method of Hamburger and Salmon (1977).
Briefly, 2 x 103 single and viable cells in I ml RPMI medium
containing 10% FCS and 0.3% agar were plated as a single
layer in 30mm bacterial dishes (Sterilin). The various
concentrations of LiCl and myo-inositol were dispersed in
the agar layer. The plates wee incubated at 37 C in 5% CO2
humidified atmosphere and the colonies were scored after 12
days.
Assessniet1t of tumorigenicity
C57/BI/6J, 6-8 week old mice, bred and supplied by the
laboratory animal unit, Beilinson Medical Center, Petah-
Tivka, Israel, were used. To test the tumorigenic potential of
untreated and LiCI treated melanoma cells, mice were
inoculated s.c. on the dorsum with 5 x 104 viable treated or
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untreated cells, suspended in 50,l PBS. Tumour growth was
quantified and expressed as tumour volume as previously
described (Nordenberg et al., 1985; 1986). Unpaired t-test
was used for statistical analysis.
Cell morphology
Cells were plated at 5 x 104 cellsml- 1 (5ml) in petri dishes
(6cm diameter) in growth medium. Two to four hours later,
after cells have been attached, LiCl at 10mm was added for
48-72 h. Cell morphology was visualized by light microscopy
following fixation and staining in situ as previously described
(Nordenberg et al., 1986; Wasserman & Icekson-Kessler,
1984). For assessment of morphology by scanning electron
microscopy (SEM) cultures were treated as previously
described (Nordenberg et al., 1986). Cells were examined by
a Jeol JSM 35 SEM (Cohen, 1974).
Deter-mination of NADPH cytochrome c reductase
For determination of NADPH cytochrome c reductase
5-7 x 105 cells were incubated in IOml cultture medium. LiCI
and myoinositol were added as indicated in legend to Table
II for 72 h. For extraction of NADPH cytochrome c
reductase, -3 x 106 cells were washed with PBS, scraped
with a rubber policeman and placed in glass tubes. Extracts
were preared by repeated (3 times) freezing and thawing of
1.5 x 106 cells in 0.1 ml Tris-HCl buffer (100mM pH=7.4)
containing MgCl2 (1 mM) and CaCl2 (1 mM).
Enzyme activity was determined spectrophotometrically at
30'C as described by Phillips and Landgon (1962) using 2,6-
dichlorphenol-indophenol as a substrate. Enzyme activity
was expressed as OD per cell number or per DNA content.
DNA was measured in the cell lysates by the method of
Burton (1956).
Results
Inhibition ofcell growth by LiCl
The effect of LiCl on cell growth in vitro was examined by
culturing melanoma cells in the absence and presence of LiCI
for 1-5 days. LiCl at 5-20mM induced a dose-dependent
inhibition in cell growth (Figure IA). Forty-eight hours of
LiCI (5 mM) treatment resulted in a decrease in B16 FIO
melanoma cell proliferation of about 50% (Figure IA).
Growth of a human amelanotic melanoma cell line (HT-144)
was also inhibited by LiCl (Figure 1B). The results depicted
in Table I show that LiCl inhibited the ability of the B16
melanoma cells to form colonies in soft agar. The effect of
LiCl was dose dependent. LiCI at 5mM decreased
clonogenicity by 58%.
Table I Inhibition of clonogenicity by LiCl and its partial
reversion by myo-inositol
Addition No. of colonies
None 132 + 35
LiCl (2.5 mM) 89 + 34
LiCl (5 mM) 55 +4
LiCl (lO mM) 17 +4
LiCI (20mM) I +2
Myo-inositol (I mM) 68 +4
LiCi (2.5 mM)+myo-inositol (I mM) 108 +39
LiCl (5 mM)+myo-inositol (I mM) 91+20
LiCI (10mM) +myo-inositol (I mM) 60+18
LiCI (20mM)+myo-inositol (I mM) 3 +2
B16 imlouse melanoma cells were plated on semi solid agar
for 12 days. Values are means+s.d. for 3-6 experiments.
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Figure 1 The effect of LiCl on melanoma cell growth. B16
mouse melanoma cells (A) or HT-144 human melanoma cells (B)
were incubated with LiCI at various concentrations for different
time intervals (D-); initial cell density (3); cell density of
incubated cultures. Vertical lines express s.d. of 3-4 experiments.
Effect of LiCI on tumorigenicity ofmnelanomal cells in
syngeneic mice
Mice injected s.c. on their dorsum with 5 x 104 viable,
untreated melanoma cells, developed spherical tumours on
their back within 10-12 days after inoculation. The tumours
killed the animals 19-30 days after inoculation. Pre-
incubation of the melanoma cells for 2-6 days with LiCl (5-
10mM) prior to inoculation of 5 x 104 viable cells, resulted in
a delay of tumour appearance (Figures 2, 3). The tumours
formed by LiCI-treated cells were significantly smaller than
those formed by untreated cells. Longer follow-up could not
be conducted, since most control mice die detween days 19-
30 after inoculation of melanoma cells. Mice inoculated with
LiCI-treated cells survived for - 10 days longer than control
mice.
Eftects of LiCIoni c-ellmorphology andicl NADPH
cv,tochromne c reductaise
Treatment of melanoma cells with LiCl altered morphology
of the cells (Figure 4). The LiCI treated cells possess very
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Figure 2 Effect of LiCl on tumorigenicity of B16 melanoma
cells. Mice were inoculated with 5 x 104 viable untreated cells
(LI). or cells that have been pretreated with LiCI (10mM) for 5
days (") Tumour appearance and size were followed as
described in Materials and methods. The results represent I out
of 4 independent experiments. Values are means of tumours from
8 mice in each group. Vertical lines represent s.e.
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Figure 3 The effect of myo-inositol on tumorigenicity of
untreated and LiCI-pretreated B16 melanoma cells. Mice were
inoculated with 5 x 104 viable untreated (O) or with 5 x 104 cells
that had been pretreated for 3 days with the following: LiCl
(5mM), El; Myo-inositol (1 mM), ;: or LiCI (5mM)+myo-
inositol (1 mM), *. Values are means of tumours from 7 mice in
each group. Vertical lines represent s.e.
Figure 4 The effect of LiCl on the morphology of B16 melanoma cells. Cells were treated with LiCl (10mM) for 2-3 days and
prepared for light and scanning electron-microscopy as described in Materials and methods. Light micrographs of untreated (A)
and LiCl-treated cells (B) (H&E, x 400). Scanning electron micrographs of untreated (C) and LiCl-treated cells (D) ( x 500).
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long dendrite-like appendages. The cells also seem to be
more flattened as compared to the untreated cells. Viability
of these cells was not reduced compared to untreated cells.
Removal of LiCI from the cultures and addition of fresh
medium resulted in reversal of the morphological alterations
within 5-7 days. Similar morphological changes were
induced by differentiating agents, such as butyric acid,
dimethylsulphoxide and retinoids in different cancer cells
(Simmons cet al., 1975; Huberman et all., 1979; Reese et al.,
1985; Nordenberg et ail., 1986; Macher et al., 1978). These
changes are thought to reflect a more differentiated state.
Melanocytic differentiation is associated with an increase
in the endoplasmic reticulum and development of Golgi
complexes (Jimbo & Vesugi, 1982; Beitner & Wennersten,
1983). We measured the effect of LiCl on the activity of
NADPH cytochrome c reductase, an enzymatic marker of
the endoplasmic reticulum.
Treatment of B16 melanoma cells with LiCI resulted in a
significant concentration dependent increase in the activity of
NADPH cytochrome c reductase (Tables II, and IV).
Table 11 The effect of LiCl on NADPH cytochrome c reductase
activity in B16 melanoma cells
NADPH c'ochrome c redluctase
Additions OD 10-8 cells nlin OD nmg - DNA min
None 3.46+0.51 2.07+0.12
LiCl (10mM) 7.42 +0.69a 5.70+0.74b
ap <0.05; bp <0.02. Cells were treated with LiCl for 3 days.
Extractions and determination were described in Materials and
methods. Values are means + s.e. for 4-8 independent
experiments.
Table Ill The effect of myo-inositol on the induction of
NADPH cytochrome c reductase activity by LiCl
Enzivme activditv
Addition ODmngDNA- I h-
None 3.7 +0.4
(5)
Myo-inositol (5mM) 5.0 +0.7
(5)
LiCI (5 nmM) 5.5 +0.6a
(5)
LiCI (t mM) +myo-inositol (5 mM) 4.7 +0.5
(5)
aLiCl vs. none, P <0.02. Enzyme was extracted and
measured as described in Materials and methods.
Number ofexperiments are given in parentheses.
Reversal
of the efrects of LiCI
by myo-inositol
It has been shown that LiCI affects phosphatidylinositol
metabolism in brain (Allison & Stewart, 1974; Allison et al.,
1976). The enzyme myo-inositol phosphate phosphatase was
shown to be inhibited by LICl in vitro (Hallcher & Sherman,
1980, Naccarato et al., 1974). We considered the possibility
that the action of LiCI on melanoma cells might be related
to an effect on phosphatidylinositol metabolism. Addition of
myo-inositol together with LiCl, or prior to LiCl to the
culture medium partially reversed the inhibitory effect of
LiCI on cell growth (Table IV) and restored the original cell
morphology (Figure 5). The degree of reversion could not be
altered by increasing myo-inositol concentrations. Myo-
inositol also reversed the effects of LiCI on clonogenicity
(Table I) and tumorigenicity (Figure 3). Interestingly, myo-
inositol by itself elicited an inhibitory effect on melanoma
Table IV Reversion of the inhibitory effects of LiCl on
cell growth by myo-inositol
Additions Cell number x 10(
None 6.5+0.9
Myo-inositol (1 mM) 5.8+0.6
Myo-inositol (5mM) 5.6 +0.2
LiCI (5mM) 2.6+0.3a
LiCl (5mM)+myo-inositol (I mM) 4.2+0.4a
LiCI (5mm) + myo-inositol (5mM) 4.5 + 0.5a
alIO B16 FI0 melanoma cells were incubated for 48h in
culture medium with and without LiCl, myo-inositol or a
comblimaion of both. Cells were counted as described in
Materials and methods. Values are means+s.e. for 5
indepcndent cxperiments. LiCl vs. none P<0.01 and LiCl+
myo-inositol vs. LiCl<0.02.
cell clonogenicity and tumorigenicity. While studying the
possible reversion of LiCl-induced activation of NADPH
cytochrome c reductase by myo-inositol we observed that
myo-inositol by itself induced this enzyme in melanoma cells.
When LiCI and myo-inositol were added together, there was
no additive or synergistic effect (Table III).
Discussion
Leukaemic cell lines can be induced to undergo terminal
differentiation by a variety of chemical agents (Friend et al.,
1971; Scher & Friend, 1973, Leder & Leder, 1975). In
contrast, cancer cell lines derived from solid tumours have
not been shown to undergo terminal differentiation by the
chemical inducers of differentiation. However, these cancer
cell lines can be induced to develop a variety of phenotypic
features, some of which characterize the mature cell
counterpart. Several studies, including our recent findings,
have shown that chemical inducers of cell differentiation
retard melanoma cell growth and tumorigenicity. Growth
inhibition was accompanied by differential effects on
melanin biosynthesis (Huberman et al., 1979; Nordenberg et
al., 1985; 1986). Normal melanocytic maturation is
characterized by melanosome formation and development of
rough endoplasmic reticulum and Golgi complexes (Beitner
& Wennersten, 1983, Jimbo & Vesugi, 1982).
LiCl is shown to exert anti-proliferative effects on
melanoma cell lines. It inhibits melanoma cell growth in
vitro, as assessed by cell counts and clonogenic assays. LiCl
also delays the growth of inoculated melanoma tumours in
syngeneic mice. Growth inhibition was accompanied by
morphological alterations and by a significant increase in the
activity of NADPH cytochrome c reductase, an enzymatic
marker of endoplasmic reticulum. Melanin content, however,
was only slighly elevated (20-70% in different experiments).
Although LiCI does not cause complete differentiation of the
melanoma cells, it does induce the appearance of phenotypic
features that are associated with the mature melanocyte.
The anti-melanoma effects of LiCI are shown to be
partially reversed by the addition of myo-inositol to cell
cultures (Tables I and IV and Figures 3 and 5).
The reversion of the effects of LiCI by addition of myo-
inositol suggests that LiCI affects melanoma cells by
interfering with phosphatidylinositol metabolism, most
probably by its inhibitory effect on myo-inositol-l-
phosphatase (Hallacher & Sherman, 1980; Naccarato et al.,
1974). Interestingly, myo-inositol, per se, exerted some anti-
proliferative effects on melanoma cells. This might offer an
explanation why reversal by myo-inositol is only partial.
Other possibilities for a partial reversion are that the carrier
systems for inositol are saturated at I mM, but cannot
provide sufficient substrate for the cell, or maybe LiCl is
acting at another site as well.GROWTH INHIBITION OF MELANOMA BY LiCI 45
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Figure 5 The effect of myo-inositol on LiCl-induced morphological alterations: (A) untreated cells; (B) cells treated with LiCl
(5mM) for 48h; (C) cells treated with LiCl (5mM) and myo-inositol (I mM) for 48h; (D) cells treated with myo-inositol (I mM) for
48 h (Papanicolaou staining, x 400).
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